Clinical trial
Study of CBX-12 in Subjects With Advanced or Metastatic Refractory Solid Tumors
NCT04902872
Study timeline
Study start (actual)2021-05-03Date precision: day
Registry last updated2026-08-20
Observed by CureCurrent2026-10-07
Recorded dates are source observations, not predictions. Missing milestones are not estimated.
Conditions
Solid Tumor, Adultunresolved
Epithelial Ovarian Cancerunresolved
Small Cell Lung Carcinomaunresolved
Breast Cancerunresolved
Colorectal Cancerunresolved
Pancreas Cancerunresolved
Appendix Cancerunresolved
Non-small Cell Lung Cancerunresolved
Gastric Cancerunresolved
Esophagus Cancerunresolved
Urothelial Carcinomaunresolved
Sarcomaunresolved
Interventions
CBX-12DRUG
Sponsors & collaborators
Cybrexa Therapeuticslead sponsor
Mapped research locations
Registry source
Open the source record to verify current eligibility, contacts, locations and registry updates.
Open NCT04902872 on ClinicalTrials.gov ↗Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.